Emerging Targets for the Pharmacological Treatment of Depression: Focus on Melatonergic System

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|3|428-437

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.3, 2012-01, pp. : 428-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Emerging Role of Melatonin Agonists in the Treatment of Major Depression: Focus on Agomelatine

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 1, 2011-02 ,pp. : 119-132

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Proteases as Emerging Pharmacological Targets

By  

Current Pharmaceutical Design, Vol. 22, Iss. 18, 2016-05 ,pp. : 2679-2688

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological treatment of adolescent depression

By  

Inpharma, Vol. 1, Iss. 1354, 2002-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Emerging targets for the treatment of scleroderma

By Leask Andrew  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 173-179

Informa Healthcare

Access to resources Recommend Favorite

Emerging Targets for the Treatment of Dyslipidemia

By  

Current Medicinal Chemistry, Vol. 18, Iss. 6, 2011-02 ,pp. : 909-922

Bentham Science Publishers

Access to resources Recommend Favorite